Compare BURL & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BURL | ZBH |
|---|---|---|
| Founded | 1972 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 19.5B |
| IPO Year | 2013 | 2001 |
| Metric | BURL | ZBH |
|---|---|---|
| Price | $317.88 | $83.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 21 |
| Target Price | ★ $355.29 | $101.00 |
| AVG Volume (30 Days) | 544.3K | ★ 2.4M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ 21.92 | N/A |
| EPS | ★ 9.51 | 3.55 |
| Revenue | ★ $11,566,910,000.00 | $8,231,500,000.00 |
| Revenue This Year | $12.72 | $4.96 |
| Revenue Next Year | $8.47 | $3.76 |
| P/E Ratio | $33.51 | ★ $23.12 |
| Revenue Growth | ★ 8.76 | 7.20 |
| 52 Week Low | $223.27 | $79.83 |
| 52 Week High | $351.85 | $108.29 |
| Indicator | BURL | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 34.54 |
| Support Level | $290.22 | N/A |
| Resistance Level | $323.17 | $96.94 |
| Average True Range (ATR) | 7.96 | 2.72 |
| MACD | -3.42 | -1.37 |
| Stochastic Oscillator | 6.55 | 19.19 |
Burlington Stores Inc is an off-price retailer offering an extensive selection of in-season, fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts, and coats. The company sells a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. It sells products in categories such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby, and Outerwear.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.